cbb86e0b-9e9c-4685-a900-c61c180c780cQ1 — 1st Quarter - Reportfederal consulting, lobbying, business development
SOUTHEAST GEORGIA HOSPITAL SYSTEM
Hospital System, three hospitals and a nursing home
VET — VeteransHR 5420 VA Extenders Act - the client has a large number of retired veterans in the area with the inability to travel to Gainsville VA, challenged with community care reimbursements.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
BUD — Budget/AppropriationsFY2027 Appropriations, ACA Subsidy Sunset, Funding for HHS/NIH, Medicare & Medicaid, Reductions of personnel at HHS, Research Funding, PACT Act with VA - funding for community care - reimbursements from VA Tracking and outreach to delegation: S.3345 - PBM Price Transparency and Accountabity Act HR 5256 - 340B Access Act HR 6240 Rural Hospital Closure Relief Act - Tracking Grid by state to compare what programs are activated
Government entities lobbied: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; SENATE
HCR — Health IssuesTracking -a federal district court vacated a Health Resources and Services Administration (HRSA) policy restricting 340B disproportionate share hospitals (DSHs) from using group purchasing organizations (GPOs) alongside replenishment models for outpatient drugs, concluding the agency failed to provide adequate justification under the Administrative Procedure Act. share hospitals (DSHs) from using group purchasing organizations (GPOs) alongside replenishment models for outpatient drugs, concluding the agency failed to provide adequate justification under the Administrative Procedure Act. Tracking Bills - S. 3206 Transgender Health Care Access Act, S. 2709 and HR 5081 Telehealth Modernization Act, HR 6468 Rural Residency Placement & Development Act of 2025 - the area is challenged with med students match with this region which challenges the ability to recruit new health care professionals to remain in the area. HR5821 - Rural Hospital Fairness Act, S891 - Bipartisan Health Act, S526 PBM Transparency Act - provides for full transparency in drug pricing to ensure any savings go back to patients - the Federal Trade Commission will complete a 6(b) study examining the effects of consolidation on pricing in the PBM industry, as well as other potentially abusive behavior by PBMs. The bill instructs the FTC to provide policy recommendations to Congress to improve competition and protect consumers. The hospital supports any mechanism for drug price transparency for patients. S527 - Prescription Pricing for People Act of 2025 - A study by FTC to study role of intermediaries (PBMs) in pharm. supply chain and provide recommendations for improvement of costs to patients. S927 Protecing Pharmacies in Medicaid Act - PBMs charge Medicaid more than they pay pharmacies for a particular drug, increases corporate profits while driving up costs for Medicaid. PBMs use of spread pricing has also been linked to the increasing failure rate for independent pharmacies, which provide a critical source of health care and community for rural communities. HR267 Health Care Transparency Act - statutory authority for requirements for hospitals and health insurance plans to disclose certain information about the costs for items and services. We need to ensure requirements are within appropriate information to be disclosed - challenged with varied reimbursement rates. HR 2214 - DRUG Act. The bill is impacting prescription drug costs, access, and manufacturing practices. These include the Inflation Reduction Act's provisions for Medicare Part D, amendments to the Federal Sentencing Guidelines, and potential changes related to PBMs and direct-to-consumer advertising. Supporting best and most affordable care for patients.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.